IP Verse

Instone competitive analysis

Loading summary...

Explore patent oppositions filed by Instone against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 30, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3210965	Process For The Preparation Of (1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-Phenol	GRNENTHAL	Aug 17, 2022
EP3366283	Direct Compression Formulation And Process	NOVARTIS	May 23, 2022
EP2667856	Medical Device Containing A Cake Composition Comprising Aripiprazole As An Active Ingredient, And A Cake Composition Comprising Aripiprazole As An Active Ingredient	OTSUKA PHARMACEUTICAL	Apr 21, 2022
EP2234617	Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters	JANSSEN PHARMACEUTICA	Dec 10, 2021
EP3021736	Contact Sensor	NEXTLIFE WEARABLES	Feb 10, 2021
EP2341905	Sustained Release Formulations Using Non-Aqueous Carriers	AMYLIN PHARMACEUTICALS	Jan 28, 2021
EP2094246	Sustained-Release Composition And Method For Producing The Same	TAKEDA PHARMACEUTICAL	Dec 16, 2020
EP3280416	Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters	JANSSEN PHARMACEUTICA	Dec 1, 2020
EP2347762	Exendin For Treating Diabetes And Reducing Body Weight	AMYLIN PHARMACEUTICALS	Jan 21, 2020
EP2598119	Preservative Free Brimonidine And Timolol Solutions	ALLERGAN	Jun 4, 2019

Discover the latest PTAB cases involving Instone, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Instone with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 30, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
INSTONE	7	-	-	-
ALCON RESEARCH	-	14	1	8
AMYLIN PHARMACEUTICALS	-	3	-	4
ASTRAZENECA PHARMACEUTICALS LP	-	7	-	-